EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 15, Issue 1, Pages 63-74
Publisher
Informa Healthcare
Online
2010-11-26
DOI
10.1517/14728222.2011.541440
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: Therapeutic considerations
- (2010) Hanna Leah Kim et al. CANCER BIOLOGY & THERAPY
- A complex interplay between Akt, TSC2 and the two mTOR complexes: Figure 1
- (2009) Jingxiang Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
- (2009) Ming-Szu Hung et al. BMC CANCER
- Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin
- (2009) X Wu et al. BRITISH JOURNAL OF CANCER
- Targeting EGFR resistance networks in head and neck cancer
- (2009) Vladimir Ratushny et al. CELLULAR SIGNALLING
- Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer
- (2009) F. G. Pernas et al. CLINICAL CANCER RESEARCH
- Molecular and Clinical Responses in a Pilot Study of Gefitinib With Paclitaxel and Radiation in Locally Advanced Head-and-Neck Cancer
- (2009) Carter Van Waes et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
- (2009) Fotios Loupakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers
- (2009) Andrew N. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity
- (2008) J. R. Garlich et al. CANCER RESEARCH
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase Dependent Cancers
- (2008) S. Chandarlapaty et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
- (2008) Amancio Carnero et al. CURRENT CANCER DRUG TARGETS
- Protein Kinase CK2 in Human Diseases
- (2008) Barbara Guerra et al. CURRENT MEDICINAL CHEMISTRY
- EGFR inhibition as a therapy for head and neck squamous cell carcinoma
- (2008) Judith Loeffler-Ragg et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inverse relationship between the length of theEGFRCA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma
- (2008) Masaya Suzuki et al. JOURNAL OF SURGICAL ONCOLOGY
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature
- (2007) Christa Lese Martin et al. ORAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started